-
1 Comment
Golden Throat Holdings Group Company Limited is currently in a long term uptrend where the price is trading 27.0% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Golden Throat Holdings Group Company Limited's total revenue sank by 53.9% to $204M since the same quarter in the previous year.
Its net income has dropped by 87.0% to $16M since the same quarter in the previous year.
Finally, its free cash flow grew by 139.4% to $25M since the same quarter in the previous year.
Based on the above factors, Golden Throat Holdings Group Company Limited gets an overall score of 3/5.
| ISIN | KYG3961J1022 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | HK |
| CurrencyCode | HKD |
| Dividend Yield | 10.% |
|---|---|
| Beta | 0.2 |
| Market Cap | 4B |
| Target Price | None |
| PE Ratio | 10.35 |
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat Lozenges over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. The company also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, it offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat intestinal series; and Golden Throat Compound Probiotic Lozenges. Further, the company exports its products to the United States, Canada, Japan, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6896.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
